Cargando…

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells

Uterine leiomyoma is the most common benign tumor of the reproductive system. Current therapeutic options do not simultaneously meet the requirements of long-term efficiency and fertility preservation. Suicide gene delivery can be proposed as a novel approach to uterine leiomyoma therapy. Non-viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egorova, Anna, Selutin, Alexander, Maretina, Marianna, Selkov, Sergei, Kiselev, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741203/ https://www.ncbi.nlm.nih.gov/pubmed/36500454 http://dx.doi.org/10.3390/molecules27238363

Ejemplares similares

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
por: Egorova, Anna, et al.
Publicado: (2020)

Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
por: Egorova, Anna, et al.
Publicado: (2021)

Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells
por: Egorova, Anna, et al.
Publicado: (2022)

Magnetic Nanoparticles as a Component of Peptide-Based DNA Delivery System for Suicide Gene Therapy of Uterine Leiomyoma
por: Shtykalova, Sofia, et al.
Publicado: (2022)

Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
por: Egorova, Anna A., et al.
Publicado: (2019)

Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells
por: Egorova, Anna, et al.
Publicado: (2021)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
por: Egorova, Anna, et al.
Publicado: (2023)

Development of Primary Monolayer Cell Model and Organotypic Model of Uterine Leiomyoma
por: Shved, Natalia, et al.
Publicado: (2022)

Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy
por: Maretina, Marianna, et al.
Publicado: (2022)

Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides
por: Egorova, Elena A., et al.
Publicado: (2022)

Development of 2′-O-Methyl and LNA Antisense Oligonucleotides for SMN2 Splicing Correction in SMA Cells
por: Maretina, Marianna, et al.
Publicado: (2023)

Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates
por: Maretina, Marianna A., et al.
Publicado: (2018)

Bladder leiomyoma presenting as uterine pedunculated leiomyoma
por: Nazari, Zeinab, et al.
Publicado: (2022)

Uterine leiomyoma with tubules
por: Pusiol, Teresa, et al.
Publicado: (2008)

Uterine Leiomyomas: An ENIGMA
por: Geethamala, Kempula, et al.
Publicado: (2016)

Ultrasonography of uterine leiomyomas
por: Woźniak, Andrzej, et al.
Publicado: (2017)

Pulmonary benign metastasizing leiomyoma from uterine leiomyoma
por: Chen, Sufeng, et al.
Publicado: (2013)

Primary Ovarian Leiomyoma Associated with Multiple Uterine Leiomyomas
por: Kitamura, Yoshihiro, et al.
Publicado: (2021)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

Multiple cutaneous and uterine leiomyomas
por: Asilian, Ali, et al.
Publicado: (2013)

Malignant transformation of uterine leiomyoma
por: Al Ansari, Afaf A., et al.
Publicado: (2013)

Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas
por: Przybyl, Joanna, et al.
Publicado: (2019)

Zosteriform pilar leiomyoma associated with uterine leiomyoma: A case report
por: Shrestha, Elisha, et al.
Publicado: (2023)

Selective Integrin α(5)β(1) Targeting through Spatially Constrained Multivalent DNA-Based Nanoparticles
por: Kurisinkal, Eva E., et al.
Publicado: (2022)

Innovative Oral Treatments of Uterine Leiomyoma
por: Sabry, Mohamed, et al.
Publicado: (2012)

Hypercalcemia: An Unusual Manifestation of Uterine Leiomyoma
por: Garcha, Amarinder Singh, et al.
Publicado: (2013)

Global metabolomic profiling of uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

Giant Uterine Leiomyoma With Surgical Difficulty
por: Mongan, Suzanna, et al.
Publicado: (2021)

Headliners: Uterine Leiomyoma: Genetic Reprogramming and Benign Uterine Tumors
por: Phelps, Jerry
Publicado: (2005)

Indications and Outcomes of Uterine Artery Embolization in Patients with Uterine Leiomyomas
por: Sasa, Hidenori, et al.
Publicado: (2012)

Mimicking uterine malignancy: Pelvic actinomycosis with giant uterine leiomyoma
por: Li, Changzai, et al.
Publicado: (2020)

Uterine Artery Doppler Velocimetry of Uterine Leiomyomas in Nigerian Women
por: Idowu, Bukunmi Michael, et al.
Publicado: (2017)

Uterine Leiomyoma in the Context of Uterine Didelphys: A Case Report
por: Defran, Asilis J, et al.
Publicado: (2023)

Pulmonary Benign Metastasizing Leiomyoma from the Uterine Leiomyoma: A Case Report
por: Kołaczyk, Katarzyna, et al.
Publicado: (2015)

Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas
por: Kim, Yoo-Na, et al.
Publicado: (2018)

Impact of Genetic Variants in Estrogen Receptor-β Gene in the Etiology of Uterine Leiomyomas
por: Bharathi, Chitroju, et al.
Publicado: (2019)

Distribution of CYP17α polymorphism and selected physiochemical factors of uterine leiomyoma in Barbados
por: Alleyne, Angela T., et al.
Publicado: (2014)

Etiology and pathogenesis of uterine leiomyomas: a review.
por: Flake, Gordon P, et al.
Publicado: (2003)

Case series: Cystic degeneration in uterine leiomyomas
por: Kaushik, Chhavi, et al.
Publicado: (2008)

Nonpuerperal uterine inversion due to submucous leiomyoma
por: Ishida, Hiroaki, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3i4d8cgr94camesbn9kfhbqv3i